Chronic Pain Related to Sacral Cysts, Neurological Dysfunction Associated With Tarlov Cysts, Sacral Tarlov Cysts, Symptomatic Sacral Cysts
Conditions
Brief summary
Brief Summary The goal of this observational study is to evaluate the long-term outcomes of different surgical techniques for sacral Tarlov cysts in adult patients aged 18-75 years diagnosed with symptomatic sacral Tarlov cysts. The main questions it aims to answer are: * Does one surgical technique result in better pain relief (measured by VAS score) and functional recovery (measured by JOA score) compared to others? * How do different surgical techniques impact the long-term recurrence rate and complication rate? Researchers will compare three surgical techniques: 1. Partial cyst wall resection with nerve root sleeve plasty. 2. Partial cyst wall resection with nerve root sleeve reinforcement and reconstruction. 3. Autologous fat/muscle with fibrin glue microscopic cyst filling. Participants will: * Undergo one of the three surgical procedures based on clinical indications. * Complete preoperative and postoperative assessments, including pain and functional scoring, as well as MRI evaluations at baseline and during follow-up. * Participate in a follow-up program for up to 2 years to monitor outcomes and recurrence.
Interventions
PROCEDUREPartial Cyst Wall Resection with Nerve Root Sleeve Plasty
Surgical technique involving partial removal of the cyst wall to decompress the nerve root, followed by plasty of the nerve root sleeve to restore nerve function and prevent recurrence.
PROCEDUREPartial Cyst Wall Resection with Nerve Root Sleeve Reinforcement and Reconstruction:
Advanced surgical technique combining partial cyst wall removal with additional reinforcement and reconstruction of the nerve root sleeve to provide enhanced support and reduce the risk of cyst recurrence.
PROCEDUREAutologous Fat/Muscle with Fibrin Glue Microscopic Cyst Filling
Minimally invasive surgical technique where autologous fat or muscle tissue is used to fill the cyst cavity, and fibrin glue is applied to seal the defect, aiming to obliterate the cyst and prevent cerebrospinal fluid leakage.
Sponsors
Beijing Jishuitan Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
1. Age 18-75 years. 2. Diagnosed with symptomatic sacral Tarlov cysts confirmed by MRI. 3. Presence of at least one of the following symptoms: * Persistent sacral or lower back pain (VAS score ≥ 4). * Neurological deficits such as lower extremity numbness or weakness. * Bowel, bladder, or sexual dysfunction attributable to the cyst. 4. Eligible for surgical intervention based on clinical evaluation. 5. Willing and able to provide written informed consent.
Exclusion criteria
1. History of prior sacral Tarlov cyst surgery. 2. Concurrent spinal conditions requiring separate surgical intervention. 3. Active infection or systemic inflammatory disease. 4. Severe comorbidities that increase surgical risk (e.g., advanced cardiac or pulmonary disease). 5. Pregnancy or lactation. 6. Inability to comply with follow-up requirements. 7. Known allergy or contraindication to surgical materials (e.g., fibrin glue).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain Reduction Assessed by Visual Analog Scale (VAS) | Baseline, 1 month, 3 months, 6 months, 12 months and 24 months postoperatively |
| Neurological Function Improvement Assessed by Japanese Orthopedic Association (JOA) Score | Baseline, 1 month, 3 months, 6 months, 12 months and 24 months postoperatively |
Secondary
| Measure | Time frame |
|---|---|
| Recurrence Rate of Sacral Tarlov Cysts | 12 months postoperatively and annually up to 2 years |
Contacts
Primary ContactLongqi Liu
Outcome results
None listed